Anderson GD - Search Results

1

Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum.

Eyal S, Kim JD, Anderson GD, Buchanan ML, Brateng DA, Carr D, Woodrum DE, Easterling TR, Hebert MF. Eyal S, et al. Among authors: anderson gd. J Clin Pharmacol. 2010 Nov;50(11):1301-9. doi: 10.1177/0091270009358708. Epub 2010 Feb 9. J Clin Pharmacol. 2010. PMID: 20145263 Free PMC article.

2

Effect of pregnancy on the pharmacokinetics of antihypertensive drugs.

Anderson GD, Carr DB. Anderson GD, et al. Clin Pharmacokinet. 2009;48(3):159-68. doi: 10.2165/00003088-200948030-00002. Clin Pharmacokinet. 2009. PMID: 19385709 Review.

3

Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum.

Hebert MF, Carr DB, Anderson GD, Blough D, Green GE, Brateng DA, Kantor E, Benedetti TJ, Easterling TR. Hebert MF, et al. Among authors: anderson gd. J Clin Pharmacol. 2005 Jan;45(1):25-33. doi: 10.1177/0091270004269704. J Clin Pharmacol. 2005. PMID: 15601802

4

Developmental pharmacokinetics.

Anderson GD. Anderson GD. Semin Pediatr Neurol. 2010 Dec;17(4):208-13. doi: 10.1016/j.spen.2010.10.002. Semin Pediatr Neurol. 2010. PMID: 21183126 Review.

5

Increases in metabolism of valproate and excretion of 6beta-hydroxycortisol in patients with traumatic brain injury.

Anderson GD, Awan AB, Adams CA, Temkin NR, Winn HR. Anderson GD, et al. Br J Clin Pharmacol. 1998 Feb;45(2):101-5. doi: 10.1046/j.1365-2125.1998.00652.x. Br J Clin Pharmacol. 1998. PMID: 9491821 Free PMC article. Clinical Trial.

6

Differences in the urinary excretion of 6-beta-hydroxycortisol/cortisol between Asian and Caucasian women.

Lin Y, Anderson GD, Kantor E, Ojemann LM, Wilensky AJ. Lin Y, et al. Among authors: anderson gd. J Clin Pharmacol. 1999 Jun;39(6):578-82. doi: 10.1177/00912709922008182. J Clin Pharmacol. 1999. PMID: 10354961

7

Bidirectional interaction of valproate and lamotrigine in healthy subjects.

Anderson GD, Yau MK, Gidal BE, Harris SJ, Levy RH, Lai AA, Wolf KB, Wargin WA, Dren AT. Anderson GD, et al. Clin Pharmacol Ther. 1996 Aug;60(2):145-56. doi: 10.1016/S0009-9236(96)90130-7. Clin Pharmacol Ther. 1996. PMID: 8823232 Clinical Trial.

8

Drug interaction potential of soy extract and Panax ginseng.

Anderson GD, Rosito G, Mohustsy MA, Elmer GW. Anderson GD, et al. J Clin Pharmacol. 2003 Jun;43(6):643-8. J Clin Pharmacol. 2003. PMID: 12817527 Clinical Trial.

9

Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid.

Levy RH, Rettenmeier AW, Anderson GD, Wilensky AJ, Friel PN, Baillie TA, Acheampong A, Tor J, Guyot M, Loiseau P. Levy RH, et al. Among authors: anderson gd. Clin Pharmacol Ther. 1990 Sep;48(3):225-35. doi: 10.1038/clpt.1990.144. Clin Pharmacol Ther. 1990. PMID: 2119269

10

Decreased plasma protein binding of valproate in patients with acute head trauma.

Anderson GD, Gidal BE, Hendryx RJ, Awan AB, Temkin NR, Wilensky AJ, Winn HR. Anderson GD, et al. Br J Clin Pharmacol. 1994 Jun;37(6):559-62. doi: 10.1111/j.1365-2125.1994.tb04304.x. Br J Clin Pharmacol. 1994. PMID: 7917774 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters